Chapel Hill, NC – Stefanie Sarantopoulos, MD, PhD, was recruited to UNC in 2009 with the help of the University Cancer Research Fund. Now she is a recipient of two grants that have helped establish her own laboratory to look into the causes of chronic Graft vs. Host Disease. Sarantopoulos is an Assistant Professor of Medicine in the Division of Hematology/Oncology and Microbiology and Immunology and a member of UNC Lineberger Comprehensive Cancer Center.
Hyundai Hope on Wheels and Raleigh-Durham Area Hyundai Dealers today awarded Ian Davis, MD, PhD, a $100,000 grant to support research into the causes of and treatments for pediatric sarcoma. Davis, assistant professor of pediatrics and genetics and a member of UNC Lineberger Comprehensive Cancer Center is one of 71 recipients of Hyundai Hope on Wheels’ 2011 Hope Grant program, where $7.1 million will be awarded to support research and programs in honor of National Childhood Cancer Awareness Month.
Men who are 40 years old or older, or who have a family history of prostate cancer, may make an appointment in advance by calling 919-966-1316. Walk-ins are also accepted.
Close to 40 participants braved Hurricane Irene to learn how to be effective advocates for lung cancer.
The UNC Comprehensive Cancer Support Program is sponsoring a monthly community educational series called “Cancer Conversations.” Featuring UNC physicians and others, the series is a time intended to help people learn from and talk with cancer experts. The sessions will be held the third Tuesday of each month from 7:00 – 8:30 pm: September 20, October 18, November 15 (no session in December).
CHAPEL HILL, N.C. It takes life-saving research to Conquer Kids’ Cancer! The St. Baldrick’s Foundation, a volunteer-driven charity dedicated to raising money for childhood cancer research, has awarded a $330,000 St. Baldrick’s Scholar award to Timothy Gershon, MD, PhD, and assistant professor of neurology at the School of Medicine at the University of North Carolina at Chapel Hill.
Chapel Hill - A UNC-led study has shown the potential for nanotechnology therapy for ovarian cancer. Scientists at UNC Lineberger Comprehensive Cancer Center and Duke University Medical Center conducted a preclinical study using nanoparticle technology to deliver doses of chemo- and radiotherapy that specifically targeted metastasized ovarian cancer cells, eradicating the cancer and lessening the toxicities often associated with the treatment.
Causes of African-American breast cancer incidence study receives $19.3M: UNC partners to form largest US database
Chapel Hill - UNC scientist Robert Millikan will partner with Christine Ambrosone, of Roswell Park Cancer Institute, and Julie R. Palmer, of Boston University, in the most ambitious study to date of breast cancer among younger African-American women.
Richard Goldberg, MD, physician-in-chief of the N.C. Cancer Hospital, is quoted in the Health section of USA Today's website.
A grant from The V Foundation for Cancer Research is helping to fund skin cancer research at UNC Lineberger.